Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative clinical study of common Chinese patent medicines for cancer-related anemia
ChiCTR2100045257Phase 4Recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Apr 2021
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Zaishengxue capsule, Taoqi Shengxue Jiaonang and Yixuesheng capsule in cancer-associated anemia (CRA) (4 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: hemoglobin and symptom and sign score. Started Apr 2021; status: recruiting.
02
Drugs
Zaishengxue capsuleTaoqi Shengxue JiaonangYixuesheng capsule
03
Conditions
cancer-associated anemia (CRA)
Beyond the preview
Go deeper on ChiCTR2100045257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045257.